Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
142.94B | 145.59B | 153.22B | 150.02B | 133.89B | 121.78B | Gross Profit |
28.03B | 28.58B | 34.63B | 32.58B | 29.37B | 18.66B | EBIT |
10.40B | 12.30B | 15.85B | 17.46B | 14.89B | 6.09B | EBITDA |
18.79B | 16.73B | 27.44B | 32.83B | 19.09B | 11.91B | Net Income Common Stockholders |
8.91B | 10.21B | 14.26B | 14.50B | 10.66B | 3.63B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
25.12B | 18.61B | 18.99B | 20.06B | 24.32B | 25.51B | Total Assets |
261.26B | 265.01B | 263.02B | 258.89B | 258.62B | 284.18B | Total Debt |
86.79B | 112.80B | 87.21B | 84.41B | 93.85B | 114.76B | Net Debt |
75.04B | 101.27B | 71.25B | 70.32B | 75.81B | 94.42B | Total Liabilities |
165.93B | 171.38B | 170.21B | 173.47B | 186.66B | 223.49B | Stockholders Equity |
94.31B | 92.63B | 91.77B | 85.42B | 71.95B | 60.69B |
Cash Flow | Free Cash Flow | ||||
13.21B | 9.07B | 6.26B | 13.41B | 19.97B | 16.59B | Operating Cash Flow |
19.14B | 17.73B | 14.47B | 16.89B | 24.55B | 22.33B | Investing Cash Flow |
-11.21B | -8.75B | -7.32B | -3.45B | -6.23B | -6.42B | Financing Cash Flow |
-13.38B | -10.75B | -8.39B | -19.03B | -19.06B | -10.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $47.80B | 7.32 | 7.02% | 5.22% | -10.13% | -37.28% | |
74 Outperform | $15.22B | 11.86 | 10.07% | 3.01% | -14.83% | 78.73% | |
73 Outperform | €47.31B | 5.03 | 5.52% | 6.83% | 1.62% | -38.38% | |
72 Outperform | $49.63B | 5.78 | 9.32% | 7.83% | -5.69% | -29.34% | |
71 Outperform | €14.33B | 33.92 | 13.95% | 1.97% | -1.57% | -26.71% | |
62 Neutral | $6.94B | 11.29 | 2.95% | 3.87% | 2.70% | -24.49% | |
58 Neutral | €10.51B | 2.07 | 5.54% | ― | ― |